John Overdeck Two Sigma Investments
John Overdeck is a co-founder of Two Sigma Investments, one of the world’s leading quantitative and technology-driven investment firms. Two Sigma applies data science, machine learning, and large-scale computing to markets across asset classes. Overdeck’s firm is a central reference point in discussions of modern systematic investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Cisco
CSCO
|
+$226M |
| 2 |
JPMorgan Chase
JPM
|
+$212M |
| 3 |
TSMC
TSM
|
+$204M |
| 4 |
Occidental Petroleum
OXY
|
+$194M |
| 5 |
Apple
AAPL
|
+$180M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$271M |
| 2 |
Microsoft
MSFT
|
+$267M |
| 3 |
Canadian Pacific Kansas City
CP
|
+$255M |
| 4 |
Thermo Fisher Scientific
TMO
|
+$226M |
| 5 |
Coca-Cola
KO
|
+$225M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.48% |
| 2 | Healthcare | 15.21% |
| 3 | Industrials | 10.23% |
| 4 | Consumer Discretionary | 10.15% |
| 5 | Financials | 9.15% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CMCT
2251
Creative Media & Community Trust
CMCT
$11.6M
| $258K | ﹤0.01% |
1
-1
| -50% | -$188K |
|
2252
Dyne Therapeutics
DYN
$4.92B
| $258K | ﹤0.01% |
26,722
-101,007
| -79% | -$860K |
|
|
TRVN
2253
DELISTED
Trevena, Inc.
TRVN
| $256K | ﹤0.01% |
745
-501
| -40% | -$158K |
|
2254
Endava
DAVA
$172M
| $253K | ﹤0.01% |
1,900
-79,574
| -98% | -$10M |
|
2255
Mammoth Energy Services
TUSK
$153M
| $253K | ﹤0.01% |
+118,958
| New | +$216K |
|
2256
Cumberland Pharmaceuticals
CPIX
$130M
| $251K | ﹤0.01% |
89,083
+6,163
| +7% | +$20.5K |
|
2257
American Outdoor Brands
AOUT
$134M
| $250K | ﹤0.01% |
19,037
-65,594
| -78% | -$1.06M |
|
|
DRRX
2258
DELISTED
DURECT Corp
DRRX
| $250K | ﹤0.01% |
37,350
+12,564
| +51% | +$87.4K |
|
2259
Laird Superfood
LSF
$46M
| $250K | ﹤0.01% |
+69,273
| New | +$471K |
|
|
MITT
2260
TPG Mortgage Investment Trust
MITT
$214M
| $250K | ﹤0.01% |
26,856
-152,109
| -85% | -$1.46M |
|
2261
First Community Bankshares
FCBC
$933M
| $249K | ﹤0.01% |
8,841
-3,148
| -26% | -$96.5K |
|
2262
Limbach Holdings
LMB
$500M
| $249K | ﹤0.01% |
35,889
-33,881
| -49% | -$266K |
|
2263
Roivant Sciences
ROIV
$26.3B
| $248K | ﹤0.01% |
50,158
+29,794
| +146% | +$197K |
|
2264
Intellicheck
IDN
$58M
| $247K | ﹤0.01% |
97,013
+77,991
| +410% | +$284K |
|
2265
Pearson
PSO
$9.98B
| $247K | ﹤0.01% |
24,745
+1,335
| +6% | +$12.1K |
|
2266
Idacorp
IDA
$7.96B
| $246K | ﹤0.01% |
+2,133
| New | +$232K |
|
2267
Westwood Holdings Group
WHG
$188M
| $246K | ﹤0.01% |
16,078
-7,969
| -33% | -$135K |
|
|
FLIC
2268
DELISTED
First of Long Island Corp
FLIC
| $245K | ﹤0.01% |
12,597
-18,305
| -59% | -$394K |
|
2269
National Bankshares
NKSH
$261M
| $243K | ﹤0.01% |
6,543
-300
| -4% | -$11K |
|
2270
Weis Markets
WMK
$1.75B
| $243K | ﹤0.01% |
3,400
-6,896
| -67% | -$457K |
|
|
OIIM
2271
DELISTED
02Micro International
OIIM
| $242K | ﹤0.01% |
58,351
-62,263
| -52% | -$251K |
|
2272
Plumas Bancorp
PLBC
$428M
| $240K | ﹤0.01% |
6,298
-303
| -5% | -$11.4K |
|
2273
United States Lime & Minerals
USLM
$3.42B
| $240K | ﹤0.01% |
10,330
-1,000
| -9% | -$24.1K |
|
2274
Casey's General Stores
CASY
$30.5B
| $239K | ﹤0.01% |
1,207
-37,036
| -97% | -$6.97M |
|
|
UROY
2275
Uranium Royalty Corp
UROY
$1.69B
| $238K | ﹤0.01% |
+60,624
| New | +$230K |
|
Similar funds
John Overdeck's Q1 2022 Portfolio in Review
As of Q1 2022, John Overdeck held 4,846 positions worth $33.9B, down 28% from $46.8B the previous quarter. Its ten largest holdings account for 7.2% of the portfolio.
John Overdeck withdrew a net $11.3B in Q1 2022, closing 2,304 positions and reducing 976 holdings. Its most notable exit was Pfizer, an estimated $271M position sold in full.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Healthcare and Industrials.
Against the trend, John Overdeck opened a new position in Cisco worth $223M.
- John Overdeck's largest Q1 2022 buy was Cisco: 4,001,362 shares worth $223M.
- John Overdeck added most to JPMorgan Chase in Q1 2022, an estimated $212M increase.
- John Overdeck's biggest Q1 2022 reduction was Coca-Cola, cutting an estimated $225M.
- John Overdeck fully exited Pfizer in Q1 2022, selling an estimated $271M.
- John Overdeck's ten largest holdings make up 7.2% of its $33.9B portfolio in Q1 2022.
- John Overdeck opened 656 new positions and closed 2,304 in Q1 2022.
- John Overdeck's portfolio value fell 28% quarter-over-quarter to $33.9B.
Based on Two Sigma Investments's 13F filing for Q1 2022, filed 16 May 2022.